| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $2.31B | $2.43B | $2.39B |
| YoY Revenue Growth % | -5.0% | +1.5% | — |
| Gross Profit | $750.2M | $801.2M | — |
| Gross Margin % | 32.5% | 33.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $34.0M | $128.2M | $200.8M |
| Operating Margin % | 1.5% | 5.3% | 8.4% |
| Net Income (GAAP) | -$31.6M | $38.1M | $109.3M |
| EBITDA (Normalized) | $82.7M | $176.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $72.8M | -$25.7M | -$222.2M |
| Capital Expenditures (CapEx) | $60.9M | $60.4M | — |
| Free Cash Flow (FCF) | $11.9M | -$86.1M | -$222.2M |
| FCF Margin % | 0.5% | -3.5% | -9.3% |
| Return on Invested Capital (ROIC %) | 2.4% | 8.5% | — |
| Cash & Short-Term Equivalents | $164.6M | $145.0M | — |
| Total Debt (Short + Long Term) | $347.5M | $347.3M | — |
| Total Stockholders' Equity | $932.8M | $993.5M | — |